TJX Companies Q2 2027 EPS Tops Expectations; Revenue Up 5%

Stock futures are steady after three days of declines. President Trump delayed 50% tariffs on Canadian imports. Target (TGT), TJX (TJX), and Lowe's (LOW) reported earnings, with Lowe's cutting its forecast. SK Hynix (SKHY) shares rose on a $29B buyback plan. Fed meeting minutes are due later.

TJX Companies shares fell 6% after reporting fiscal Q2 2027 results. Comparable sales at its Marmaxx segment rose 1% vs. expected 3%, while revenue increased 5.4% to $15.18B and EPS rose 10.9% to $1.22. CEO Ernie Herrman attributed the miss to inventory issues, but some analysts downgraded the stock.

The Treasury announced it would double buybacks of longer-term notes, causing 30-year Treasury yields to drop to 5.194% and the Dow Jones to close up 0.22%. Fed minutes indicated potential rate hikes if inflation persists. Moderna's stock surged 175% after successful cancer vaccine trial data. Bitcoin rose above $68,000, driven by Treasury optimism and crypto legislation interest.

TJX Companies reported a slowdown in its TJ Maxx and Marshalls apparel divisions, despite strong home goods growth. CEO Ernie Herrman attributed the slowdown to execution issues. Shares fell 4.2%. The company raised its annual profit forecast and maintained sales growth targets. TJX faces competition from Ross Stores and Burlington Stores. Q2 net sales rose 5.4% to $15.18B, beating estimates. Q3 EPS guidance was $1.30-$1.32, below analyst expectations of $1.35.

TJX reported Q2 net sales of $15.18B, up 5% YoY, and comp sales growth of 4%, surpassing internal projections. The off-price retailer attributed the growth to strong customer demand and strategic inventory management.

TJX reported Q2 EPS of $1.22, beating estimates by $0.03, with revenue at $15.2B, slightly above expectations. The company forecasted FY 2027 EPS of $5.15-$5.20. TJX's stock is down 4.69% over the last 3 months but up 9.10% year-over-year, with a 'good performance' financial health score according to InvestingPro.